RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
1-Year Est. Return
12.81%
1 Year Est. Return
+12.81%
AUM
$870M
AUM Growth
-$103M
(-11%)
Holding
104
Top Buys
| 1 | +$23M | |
| 2 | +$19.8M | |
| 3 | +$11.2M | |
| 4 |
Molina Healthcare
MOH
|
+$11.2M |
| 5 |
DexCom
DXCM
|
+$10.6M |
Top Sells
| 1 | +$21.9M | |
| 2 | +$21.4M | |
| 3 | +$16.5M | |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$14.7M |
| 5 |
Boston Scientific
BSX
|
+$14.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Oscar Health
OSCR
$5.15B
| $13.4M | 1.54% |
1,022,743
-339,678
|
|
||
27
Alnylam Pharmaceuticals
ALNY
$62.7B
| $13M | 1.5% |
48,197
+31,197
|
|
||
28
Royalty Pharma
RPRX
$15.7B
| $12.8M | 1.47% |
411,000
-184,000
|
|
||
29
Axsome Therapeutics
AXSM
$6.74B
| $12.8M | 1.47% |
109,600
-13,000
|
|
||
30
Humana
HUM
$35.6B
| $12.4M | 1.42% |
46,830
-8,400
|
|
||
|
31
DexCom
DXCM
$26.9B
| $10.6M | 1.22% |
+155,000
|
|
||
32
Neurocrine Biosciences
NBIX
$14.7B
| $9.93M | 1.14% |
89,817
-10,500
|
|
||
33
Zimmer Biomet
ZBH
$20.1B
| $9.87M | 1.14% |
87,250
-36,750
|
|
||
34
Cigna
CI
$82.8B
| $9.28M | 1.07% |
28,200
-50,185
|
|
||
35
Cencora
COR
$64.9B
| $9M | 1.03% |
32,375
-21,375
|
|
||
36
Danaher
DHR
$154B
| $8.6M | 0.99% |
41,952
-22,000
|
|
||
37
Centene
CNC
$16.4B
| $7.65M | 0.88% |
126,000
-69,482
|
|
||
38
Dynavax Technologies
DVAX
$1.23B
| $7.33M | 0.84% |
565,000
-274,131
|
|
||
39
TG Therapeutics
TGTX
$5.46B
| $7M | 0.8% |
177,500
-85,000
|
|
||
40
Abbott
ABT
$220B
| $6.9M | 0.79% |
52,000
-76,000
|
|
||
41
Biogen
BIIB
$21.8B
| $6.77M | 0.78% |
49,500
-74,200
|
|
||
42
Align Technology
ALGN
$9.69B
| $6.59M | 0.76% |
41,500
-400
|
|
||
43
Thermo Fisher Scientific
TMO
$211B
| $6.29M | 0.72% |
12,640
-3,000
|
|
||
44
HCA Healthcare
HCA
$109B
| $5.8M | 0.67% |
16,778
-17,601
|
|
||
45
Syndax Pharmaceuticals
SNDX
$1.19B
| $5.32M | 0.61% |
433,000
+201,000
|
|
||
|
AVR
46
Anteris Technologies
AVR
$176M
| $4.7M | 0.54% |
+1,290,000
|
|
||
47
Astrana Health
ASTH
$1.59B
| $4.65M | 0.53% |
150,000
+70,000
|
|
||
|
VRNA
48
DELISTED
Verona Pharma
VRNA
| $4.44M | 0.51% |
+70,000
|
|
||
49
Becton Dickinson
BDX
$52.9B
| $4.35M | 0.5% |
19,000
-28,900
|
|
||
50
Cytokinetics
CYTK
$7.37B
| $4.19M | 0.48% |
104,250
-45,000
|
|